FDA announcement generates news


News
10 new results for multiple sclerosis

FDA warns against multiple sclerosis treatment
Los Angeles Times
The experimental 'liberation therapy,' which involves widening veins in the head and neck to alleviate MS symptoms, has caused death and has no proven benefit, the agency says. By Ian Duncan, Los Angeles Times WASHINGTON — An experimental treatment ...
See all stories on this topic »
FDA Issues Warning About Experimental MS Therapy
ABC News
The US Food and Drug Administration issued a warning about the potential risks of an experimental therapy used to treat a condition -- chronic cerebrospinal venous insufficiency, or CCSVI -- often linked to multiple sclerosis. CCSVI is characterized by ...
See all stories on this topic »
FDA Warns of Multiple Sclerosis Treatment
Wall Street Journal
By THOMAS M. BURTON The Food and Drug Administration on Thursday warned that a controversial treatment for multiple sclerosis has been tied to serious complications, including stroke and death. Known to some backers as "liberation therapy," the ...
See all stories on this topic »
Experimental Multiple Sclerosis Treatment Could Be Dangerous And Even Deadly: FDA
Huffington Post
By Anna Yukhananov WASHINGTON, May 10 (Reuters) - US drug regulators are warning people with multiple sclerosis that an experimental treatment that props open internal veins in the neck and chest can cause death or serious injury.
See all stories on this topic »
FDA Issues Warning on Controversial MS Treatment
Philadelphia Inquirer
THURSDAY, May 10 (HealthDay News) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the US Food and Drug Administration said ...
See all stories on this topic »
FDA warns MS patients about risky stent treatment
msnbc.com
US drug regulators are warning people with multiple sclerosis to avoid an experimental treatment that props open internal veins in the neck and chest, because it can cause death or serious injury. Don't miss these Health stories 'Stronger': Patient's ...
See all stories on this topic »
FDA Warns MS Patients Against Unproven Stent Procedure
BusinessWeek
By Michelle Fay Cortez on May 10, 2012 The US Food and Drug Administration warned doctors and patients against the use of an unproven procedure known as “liberation therapy” that some physicians have touted as a treatment for multiple sclerosis.
See all stories on this topic »
FDA issues warning about controversial MS treatment
OCRegister
By COURTNEY PERKES / THE ORANGE COUNTY REGISTER The Food and Drug Administration on Thursday issued a safety alert about an experimental treatment for multiple sclerosis a year after a Canadian woman died from the procedure in Orange County.
See all stories on this topic »
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
FDA.gov
Some researchers believe that CCSVI, which is characterized by a narrowing (stenosis) of veins in the neck and chest, may cause multiple sclerosis (MS) or may contribute to the progression of the disease by impairing blood drainage from the brain and ...
See all stories on this topic »
FDA Warns on Controversial MS Therapy
MedPage Today
By John Gever, Senior Editor, MedPage Today WASHINGTON -- The FDA has issued an alert warning about risks, including death, associated with endovascular treatments for multiple sclerosis based on the controversial theory that the disease is caused or ...
See all stories on this topic »


Blogs
3 new results for multiple sclerosis

FDA issues warning on controversial MS treatment
(HealthDay) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and Drug Administration said in an alert ...
Medical Xpress - latest medical...
FDA Issues Warning on Controversial MS Treatment - Drugs.com ...
Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called libera.
Drugs.com - Daily MedNews
NDA Accepted for BG-12 for Multiple Sclerosis - MPR
Biogen Idec announced that the FDA has accepted for filing the company's New Drug Application (NDA) for BG-12 (dimethyl fumarate) for the treatment of multiple sclerosis (MS).
Latest articles from MPR

Web
2 new results for multiple sclerosis

FDA warns MS patients about risky treatment - Yahoo! News
From Yahoo! News: WASHINGTON (Reuters) - U.S. drug regulators are warning people with multiple sclerosis that an experimental treatment that props open ...
news.yahoo.com/fda-warns-ms-patients-risky-stent-treatment-...
Acupuncture & PEA for Multiple Sclerosis Pain
Acupuncture combined with PEA helps to control multiple sclerosis related pain.
www.healthcmi.com/.../540-acupunctureceuspeamultiplesclero...

Labels: , ,